Metagenomi Therapeutics, Inc.
MGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001785279
In the last 90 days, Metagenomi Therapeutics, Inc. insiders filed 1 open-market purchase and 3 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $7.45M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Metagenomi Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 69 | 2 | 58 | −9 |
| Shares | 7.70M | 452.3K | 6.00M | −1.25M (−17.2%) |
| Value | $10.4M | $669.4K | $14.2M | +$4.46M (+45.9%) |
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Metagenomi Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 71,266 | $168.9K | 0.00% |
| Man Group plc | 52,888 | $125.3K | 0.00% |
| Two Sigma Advisers, LP | 50,400 | $119.4K | 0.00% |
| Dynamic Technology Lab Private Ltd | 27,178 | $64.0K | 0.01% |
| XTX Topco Ltd | 15,216 | $36.1K | 0.00% |
| Two Sigma Securities, LLC | 12,189 | $28.9K | 0.00% |
| Royal Bank of Canada | 615 | $1.00K | 0.00% |
| SRS Capital Advisors, Inc. | 30 | $71 | 0.00% |
| Optiver Holding B.V. | 18 | $43 | 0.00% |
Sold out (18)
Institutions that held Metagenomi Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| AQR Capital Management LLC | 129,055 | $191.0K |
| Goldman Sachs Group Inc | 108,596 | $160.7K |
| Susquehanna International Group, LLP | 72,587 | $107.4K |
| Citadel Advisors LLC | 60,624 | $89.7K |
| Squarepoint Ops LLC | 38,126 | $56.4K |
| Jain Global LLC | 28,645 | $42.4K |
| Brown Advisory Inc | 25,006 | $37.0K |
| SG Americas Securities, LLC | 18,711 | $28.0K |
| Virtu Financial LLC | 19,008 | $28.0K |
| Verition Fund Management LLC | 13,892 | $20.6K |
| Prudential Financial Inc | 13,400 | $19.8K |
| Catalyst Funds Management Pty Ltd | 12,700 | $18.8K |
| Tower Research Capital LLC (TRC) | 12,375 | $18.3K |
| Ground Swell Capital, LLC | 12,198 | $18.1K |
| Spire Wealth Management | 6,500 | $9.62K |
| Deutsche Bank AG | 5,349 | $7.92K |
| Raymond James Financial Inc | 157 | $232 |
| Clearstead Advisors, LLC | 130 | $193 |
Not filed for Q3 2025 yet (2)
Institutions that held Metagenomi Therapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Norges Bank | 252,310 | $373.4K |
| Good Life Advisors, LLC | 200,000 | $296.0K |